Almond Butter and Fasting Glucose

Clinical Trial ID: NCT03826472

Description

A two-period randomized crossover study will be conducted to determine the effect of almond butter as an evening snack on fasting blood glucose in adults with type 2 diabetes, not taking insulin.

Control of fasting blood glucose is a challenge for many individuals with diabetes. Researchers want to better understand how a nighttime snack can affect morning fasting blood glucose. A two-period randomized crossover trial will be conducted. Participants will be randomized to receive each treatment for 1 week. During the almond butter treatment, participants will consume 2 tbsp of almond butter per day as an evening snack. The control treatments will be a no-snack control. Fasting blood glucose, as well as glucose trends, will be measured using Continuous Glucose Monitor (CGM). Participants will also be asked to take simple cognitive tests on a study-provided smartphone each day of the study and report their daily food intake and physical activity.


Criteria

Inclusion Criteria: - Individuals with diagnosed type 2 diabetes - Not on insulin therapy - On stable does of oral antihyperglycemic agent (no dose change for 6 months) - Currently monitoring blood glucose at home via glucometer - Willing and able to adhere to study protocol Exclusion Criteria: - Individuals with type 1 diabetes, cardiovascular disease, kidney disease, liver disease, cancer or inflammatory conditions (e.g. GI disorders, rheumatoid arthritis) - Women who are pregnant, breastfeeding, or have been pregnant within the last 6 months or breastfeeding within the last 6 weeks - Individuals who smoke or use tobacco products - Use of insulin therapy or sulfonylurea medications - Allergy to any tree nut - Liver or kidney disease - Allergy to Dexcom CGM adhesive

  • Start Date

    2019-03-08

  • Last Updated

    2019-03-08

  • Sponsor

    Penn State University

  • Condition Name

    Type2 Diabetes

Learn about this trial.

Check the eligibility requirements, study details, and more.

Related Trials

Different trials target different symptoms, condition types, and patients. Learn more about other emergeing treatments being investigated now.